Working… Menu

Vitamin D Supplementation Can Improve Heart Function in Idiopathic Cardiomyopathy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02517814
Recruitment Status : Unknown
Verified August 2015 by Hillel Yaffe Medical Center.
Recruitment status was:  Not yet recruiting
First Posted : August 7, 2015
Last Update Posted : August 7, 2015
Information provided by (Responsible Party):
Hillel Yaffe Medical Center

Brief Summary:
Vitamin D deficiency could be a high risk for cardiovascular diseases. It has been recently reported that vitamin D deficiency is another cause of heart failure and cardiomyopathies. It was found that vitamin D supplementation improved the heart function. The purpose of this study is to evaluate patients with idiopathic cardiomyopathies and determine whether vitamin D supplementation in cases where there is a deficiency, improves heart functioning.

Condition or disease Intervention/treatment Phase
Cardiomyopathy, Dilated Dietary Supplement: Vitamin D Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 100 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Study Start Date : October 2015
Estimated Primary Completion Date : October 2016
Estimated Study Completion Date : October 2016

Arm Intervention/treatment
Experimental: Patients with cardiomyopathy
Patients with vitamin D deficiency and cardiomyopathy will receive supplementation with vitamin D 400 units per day for 6 months.
Dietary Supplement: Vitamin D

Primary Outcome Measures :
  1. Number of participants with Improvement of heart function [ Time Frame: 6 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients with idiopathic cardiomyopathy

Exclusion Criteria:

  • Post heart surgery
  • Congenital heart disease

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02517814

Layout table for location contacts
Contact: Eias Kassem, MD 972-4-6304331

Layout table for location information
Hillel Yaffe Medical Center
Hadera, Israel, 38100
Sponsors and Collaborators
Hillel Yaffe Medical Center

Layout table for additonal information
Responsible Party: Hillel Yaffe Medical Center Identifier: NCT02517814     History of Changes
Other Study ID Numbers: HY-2015-06
First Posted: August 7, 2015    Key Record Dates
Last Update Posted: August 7, 2015
Last Verified: August 2015
Additional relevant MeSH terms:
Layout table for MeSH terms
Cardiomyopathy, Dilated
Heart Diseases
Cardiovascular Diseases
Vitamin D
Growth Substances
Physiological Effects of Drugs
Bone Density Conservation Agents
Calcium-Regulating Hormones and Agents